ClinicalTrials.gg
Active, not recruitingNCT02591563AOMUpdated Oct 19, 2026

Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.

An observational study in Nasopharyngeal Colonization and Acute Otitis Media, sponsored by Rochester General Hospital. Active, not recruiting at 1 site in United States. Open to participants aged 6 Months to 36 Months, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Rochester General Hospital · Observational

Updated Oct 19, 2026Primary completion movedStudy completion movedGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,320
Ages
6 Months to 36 Months
Sex
All
01

Study summary

The purpose of this study is to Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.

Read the detailed description

A prospective evaluation of bacterial pathogens Streptococcus. pneumoniae, Haemophilus influenzae, Moraxella. catarrhalis and Staphylococcus aureus and their antibiotic susceptibility when colonizing the nasopharynx and/or causing acute otitis media in the years 2015-2025. The goal will be to recruit children into a prospective group beginning at 6 months of age and followed to 36 months of age in suburban Rochester, New York. Nasopharyngeal and nasal wash samples will be obtained at each well child visit and at acute otitis media (AOM) episodes. Middle ear fluid will be obtained from every child with an acute otitis media episode who undergoes a tympanocentesis procedure. All of the nasopharyngeal and middle ear fluid samples collected will be tested by standard microbiologic techniques to identify the presence of 4 potential otopathogens (S. pneumoniae, H. influenzae, M. catarrhalis and S. aureus). All S. pneumoniae will undergo serotyping and antibiotic susceptibility testing. All samples that are culture negative will be evaluated with a multi-locus PCR test to examine for presence of potential otopathogens.

02

Conditions studied

  • Nasopharyngeal Colonization and Acute Otitis Media

Browse trials for

03

In context

Otitis Media

241 studies on the registry are indexed under Otitis Media; 32 are open to participants now.

This study's enrollment of 1,320 is above the median of 150 across 57 observational studies indexed under Otitis Media.

Browse Otitis Media studies →

Lead sponsor

Rochester General Hospital is the lead sponsor of 11 studies on the registry; 2 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Months to 36 Months
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy 6-36 month old children or Acute Otitis Media diagnosed children >/= 6mo but \</= 36 months

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Healthy Children:

  • Male or female age greater than/equal to 6 months or less than/equal to 36 months old.
  • Parent/guardian willing to bring to all study visits

Exclusion criteria

Exclusion Criteria:

  • Any major illness/condition that in investigator opinion would put subject at risk during study.
  • Otorrhea or tympanostomy tubes present in either ear @ time of enrollment.
  • Direct descendant of study site personnel.
  • Subjects \< 6 months old or >36 months old at the time of enrollment
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,320 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • Healthy children

    6-36 months of age who will have the following study procedures: Venipuncture, Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis

    Other: procedures

Interventions

  • Otherprocedures

    Nasopharyngeal swab, nasopharyngeal wash, tympanocentesis (if acute otitis media occurs), venipuncture

06

What researchers measure

Primary outcomes

  1. The distribution of bacteria causing acute otitis media.

    In this study, we are exploring the three main bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) isolated from middle ear fluid samples (obtained by tympanocentesis) during acute otitis media episode in children ages 6-36 months.

    Time frame: 10 years

Secondary outcomes

  1. The distribution of potential otopathogens colonizing the nasopharynx.

    In this study we are exploring the three main bacteria (Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis) isolated from nasopharynx of children during their routine healthy visits at 6-36 months of age during an AOM episode.

    Time frame: 10 years

07

Study locations

1 site
08

Updates

1 registry update since Sep 25, 2026
Primary completion
Dec 2025→Dec 2027
Oct 19, 2026
Study completion
Dec 2025→Dec 2027
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    Primary completion Dec 2025→Dec 2027
    Study completion Dec 2025→Dec 2027
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT02591563
Lead sponsor
Rochester General Hospital
Responsible party
Michael Pichichero (MD, Director, Rochester General Hospital Research Institute, Rochester General Hospital) — Principal investigator
First posted
Oct 29, 2015
Start date
Oct 1, 2015
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 19, 2026

Study contacts

Michael E Pichichero, MD
principal investigator · Rochester General Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion